Literature DB >> 15826740

Bipolar disorder and substance abuse.

E Sherwood Brown1.   

Abstract

SUDs are common in people with BPD. The reasons for this association are not well understood and may be related to several factors. When present,SUDs in BPD patients seem to be associated with a poor prognosis. The treatment of patients with BPD and an SUD has been the subject of relatively little investigation, but medications that are effective mood stabilizers seem to decrease substance use in some reports.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15826740     DOI： 10.1016/j.psc.2005.01.004

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  11 in total

1.  A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Authors:  E Sherwood Brown; Prabha Sunderajan; Lisa T Hu; Sharon M Sowell; Thomas J Carmody
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Evaluation of tissue collection for postmortem studies of bipolar disorder.

Authors:  Amy Deep-Soboslay; Bianca Iglesias; Thomas M Hyde; Llewelyn B Bigelow; Vesna Imamovic; Mary M Herman; Joel E Kleinman
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

3.  Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder?

Authors:  Jules Angst; Alex Gamma; Jérôme Endrass; Wulf Rössler; Valdeta Ajdacic-Gross; Dominique Eich; Richard Herrell; Kathleen Ries Merikangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

4.  No evidence for association between 19 cholinergic genes and bipolar disorder.

Authors:  Jiajun Shi; Eiji Hattori; Hongwei Zou; Judith A Badner; Susan L Christian; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

5.  ANKRD7 and CYTL1 are novel risk genes for alcohol drinking behavior.

Authors:  Xiang-ding Chen; Dong-hai Xiong; Tie-lin Yang; Yu-fang Pei; Yan-fang Guo; Jian Li; Fang Yang; Feng Pan; Li-jun Tan; Han Yan; Xiao-gang Liu; Shu-feng Lei; Xi Li; Ling-ling Ning; Xue-zhen Zhu; Shawn Levy; Henry R Kranzler; Lindsay A Farrer; Joel Gelernter; Robert R Recker; Hong-wen Deng
Journal:  Chin Med J (Engl)       Date:  2012-03       Impact factor: 2.628

6.  Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.

Authors:  Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2011-01       Impact factor: 1.325

7.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Authors:  Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-05

Review 8.  A role for the circadian genes in drug addiction.

Authors:  Edgardo Falcón; Colleen A McClung
Journal:  Neuropharmacology       Date:  2008-07-03       Impact factor: 5.250

9.  Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.

Authors:  Bernardo Dell'Osso; Massimiliano Buoli; Riccardo Riundi; Nazario D'Urso; Sara Pozzoli; Roberta Bassetti; Emanuela Mundo; A Carlo Altamura
Journal:  Neuropsychiatr Dis Treat       Date:  2009       Impact factor: 2.570

10.  Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry.

Authors:  Icro Maremmani; Angelo Giovanni Icro Maremmani; Fabio Rugani; Luca Rovai; Matteo Pacini; Silvia Bacciardi; Joseph Deltito; Liliana Dell'osso; Hagop S Akiskal
Journal:  Ann Gen Psychiatry       Date:  2012-09-03       Impact factor: 3.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.